| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.2 | 0.003 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |